Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
about
Pleiotropic effects of statins in the diseases of the liverStatin Use and Risk of Cirrhosis and Related Complications in Patients with Chronic Liver Diseases: a Systematic Review and Meta-analysis.Statins intake and risk of liver cancer: A dose-response meta analysis of prospective cohort studiesBeneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.Meta-analysis of studies using statins as a reducer for primary liver cancer risk.The Relationship between Serum Bilirubin and Elevated Fibrotic Indices among HBV Carriers: A Cross-Sectional Study of a Chinese Population.Novel treatment options for portal hypertension.Current and future treatment options in non-alcoholic steatohepatitis (NASH).Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.Rationale for the use of statins in liver disease.Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.Statins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studies.Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.Nonalcoholic fatty liver disease: Evolving paradigms.Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.Advances and challenges in cirrhosis and portal hypertension.Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.Managing portal hypertension in patients with liver cirrhosis.Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
P2860
Q26741176-E5231977-5BF2-46D5-8B6F-566EB6BCAABBQ30234533-E88C9EA8-7FF8-4491-9D92-97BDDD2318F2Q33885894-E585996F-ABAE-4F3A-94F0-0218A192F230Q36393781-CA4A2BC4-10C3-47E8-8012-D29F4C9A455EQ36919251-55D2B922-1F3E-4761-A993-8F9A6593D2B8Q37534729-5D6AB275-AADA-45E0-840F-72576E19FE60Q38680437-008A0C63-78E0-4B10-B36F-EB32B69B16EDQ38748381-87463C54-BD66-4E92-9464-3DD64B05C91BQ38974667-32EED1FF-B11B-46CB-B0D2-28F1911EF9E1Q39171942-8A46BDFC-1E77-46DB-9A10-9B0917EFAC5AQ40267682-A436D696-F967-4617-90F2-8819D04FA97CQ41708780-3A687B05-893D-4416-851A-89EC120014DEQ41919194-67811757-A6DD-4786-8731-14E54EAB79F5Q41921861-0659A472-E8E3-41BA-BD0B-5C6CD16BF96DQ41931638-ABB9AC52-DB98-4735-BA11-1837CF75388BQ41934639-8958F2EB-F358-48DD-AF77-ADD3EE85F78EQ42695154-E72E3263-7265-4B25-BEEC-F9838CCF84FFQ45324158-6E105779-CD08-45BB-BC02-B07A3B4DE672Q47095006-833F7FDE-D188-4013-934D-86DEA66D961EQ47547628-C0B7725D-2091-4F11-8815-DAB8CD5E6439Q47590039-B3F29C8B-DDAA-4A18-8588-CD0BCAD68B9DQ52686485-7C69B7C0-ED24-457D-84D3-498A0BB87C8FQ55278061-B7E207E3-13CE-4D87-85AA-1227103898E9Q58785077-E5E4817D-C263-4CE8-AC9B-2FAD27901734
P2860
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@en
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@nl
type
label
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@en
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@nl
prefLabel
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@en
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@nl
P2093
P2860
P356
P1433
P1476
Atorvastatin and fluvastatin a ...... virus: Results from ERCHIVES.
@en
P2093
Adeel A Butt
Hector Bonilla
Tracey G Simon
P2860
P356
10.1002/HEP.28506
P407
P577
2016-02-18T00:00:00Z